DOCSLIB.ORG

Donald Kennedy Personal Papers

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Donald Kennedy Personal Papers http://oac.cdlib.org/findaid/ark:/13030/kt2q2nf28s Online items available Guide to the Donald Kennedy Personal Papers Daniel Hartwig Stanford University. Libraries.Department of Special Collections and University Archives Stanford, California October 2010 Copyright © 2015 The Board of Trustees of the Leland Stanford Junior University. All rights reserved. Note This encoded finding aid is compliant with Stanford EAD Best Practice Guidelines, Version 1.0. Guide to the Donald Kennedy SC0708 1 Personal Papers Overview Call Number: SC0708 Creator: Kennedy, Donald, 1931- Title: Donald Kennedy personal papers Dates: 1975-2007 Physical Description: 15.5 Linear feet Summary: This collection contains his speech files dating from 1975 to 2007; these include Stanford events, commencements at other universities, conferences, government testimony, memorials, and others. There is also an unprocessed accession (2003-003) which includes his personal copies of congressional hearings while serving as FDA Commissioner. Language(s): The materials are in English. Repository: Department of Special Collections and University Archives Green Library 557 Escondido Mall Stanford, CA 94305-6064 Email: [email protected] Phone: (650) 725-1022 URL: http://library.stanford.edu/spc Information about Access Access: Please consult the University Archivist for access to the unprocessed materials. Ownership & Copyright All requests to reproduce, publish, quote from, or otherwise use collection materials must be submitted in writing to the Head of Special Collections and University Archives, Stanford University Libraries, Stanford, California 94304-6064. Consent is given on behalf of Special Collections as the owner of the physical items and is not intended to include or imply permission from the copyright owner. Such permission must be obtained from the copyright owner, heir(s) or assigns. See: http://library.stanford.edu/depts/spc/pubserv/permissions.html. Restrictions also apply to digital representations of the original materials. Use of digital files is restricted to research and educational purposes. Cite As Donald Kennedy Personal Papers (SC0708). Dept. of Special Collections and University Archives, Stanford University Libraries, Stanford, Calif. Biographical/Historical Sketch Kennedy, holder of three degrees from Harvard, joined Stanford's biology faculty in 1960; while on leave from 1977 to 1979 he served in Washington, D.C., as commissioner of the Food and Drug Administration. Kennedy was Stanford's eighth president, serving from 1980 to 1992. Prior to taking office he was vice president and provost under his predecessor Richard W. Lyman. During his presidency, Stanford celebrated its centennial and its full emergence as a world-class university. Kennedy was at the forefront of the university's student public service initiative and efforts to renew faculty commitment to teaching. His term in office also included the university's disagreement with the federal government over reimbursement for the indirect costs of research. Description of the Collection This collection contains his speech files dating from 1975 to 2007; these include Stanford events, commencements at other universities, conferences, government testimony, memorials, and others. There is also an unprocessed accession (2003-003) which includes his personal copies of congressional hearings while serving as FDA Commissioner. Access Terms Kennedy, Donald, 1931- Universities and colleges--Administration. Accession ARCH-2003-003 Papers Box 1 DK's personal copies of congressional hearings while serving as FDA Commissioner Guide to the Donald Kennedy SC0708 2 Personal Papers Accession ARCH-2003-003Papers Box 2 DK's personal copies of congressional hearings while serving as FDA Commissioner Box 3 Books Box 4 Books Box 5 Books Box 6, Folder 1 Ice Cream 1974-1979 Box 6, Folder 2 Laetrile 1978-1979 Box 6, Folder 3 Acrylonitrile 1976-1977 Box 6, Folder 4 Darvon 1978-1979 Box 6, Folder 5 Lead 1974-1978 Box 6, Folder 6 Lead Acetate 1978-1979 Box 6, Folder 7 Liquid Proton 1977-1978 Box 6, Folder 8 Nitrite 1972-1979 Box 6, Folder 9 Saccharin 1977-1979 Box 6, Folder 10 Sodium Valproate 1977-1978 Box 6, Folder 11 Alpha-Fetoprotein 1978-1980 Box 6, Folder 12 Phenformin 1977-1979 Box 6, Folder 13 Dr. Frank Morrell 1969-1974 Box 6, Folder 14 H. Bruce Franklin 1/5 1971-1972 Box 6, Folder 15 H. Bruce Franklin 2/5 1971-1972 Box 6, Folder 16 H. Bruce Franklin 3/5 1971-1972 Box 6, Folder 17 H. Bruce Franklin 4/5 1971-1972 Box 6, Folder 18 H. Bruce Franklin 5/5 1971-1972 Box 6, Folder 19 SIDS + DTP Vaccine 1979 Box 6, Folder 20 A Proposed FDA Program to Reduce Unnecessary Patient Exposure From Diagnostic X Rays: Cost Containment Considerations 1978 Box 6, Folder 21 PMS Briefing to the Commissioner Ionizing Radiation--Products and Devices Ionizing Radiation--Use Control 28265 Box 6, Folder 22 FDA Related Correspondence 1980-1983 Box 6, Folder 23 FDA Related Manuscripts 1979-1982 Box 6, Folder 24 FDA Consumer Magazine Article 1980-1981 Box 6, Folder 25 FDA--Info Only 1978-1984 Box 6, Folder 26 OSTP--Recombinant DNA--Background, Etc. 1/2 1976-1977 Box 6, Folder 27 OSTP--Recombinant DNA--Background, Etc. 2/2 1976-1977 Box 7, Folder 1 Professional Appointments 1994 Box 7, Folder 2 Professional Appointments 1995 Box 7, Folder 3 Professional Appointments 1991 Box 7, Folder 4 Professional Appointments 1990 Box 7, Folder 5 Cassette: Donald Kennedy, "New Tests for SCIENCE" 2001 Box 7, Folder 6 "New threat to research funds" 29990 Box 7, Folder 7 Asahi Shimbun, Tokyo 31745 Box 7, Folder 8 The Politics of Preventive Health by Donald Kennedy 1981 Box 7, Folder 9 Cleaning up the Smog Act (DK Info) 29618 Box 7, Folder 10 The Promise of Fact (DK info) 29707 Box 7, Folder 11 Recommendations and Correspondence involving Donald Kennedy 1981 Box 7, Folder 12 Brochure: How can we look so rich, yet feel so poor? 31487 Box 7, Folder 13 Forty-First Meeting of the Trustees of Midwest Research Institute 31554 Box 7, Folder 14 Basic Research in the Universities: How Much Utility? 1986 Box 7, Folder 15 Addreses and Proceedings--The Idea of Education: Rediscovery of Purpose in a Brave New World 4/12-13/1984 Box 7, Folder 16 "Business, Science and the Universities" 29726 Box 7, Folder 17 Health Affairs Fall 1983 1983 Box 7, Folder 18 Academy News--"Stanford's President Takes a Long-Range look" 1985 Box 7, Folder 19 Brandeis University: Inauguration of Evelyn Erika Handler` 30608 Box 7, Folder 20 Technology Review 1981 Box 7, Folder 21 Educating for the Twenty-First Century 1985-1986 Box 7, Folder 22 Scroll by TRL 1971 Box 7, Folder 23 Bay Area Business (DK info) 1986 Box 7, Folder 24 Mobius, A Journal for Continuing Education Professional in Health Sciences 1981 Guide to the Donald Kennedy SC0708 3 Personal Papers Accession ARCH-2003-003Papers Box 7, Folder 25 The Stanford Magazine Winter 1982 1982 Box 7, Folder 26 Loose Articles 1983-1987 Box 7, Folder 27 1980 Articles 1980 Box 7, Folder 28 Equal Opportunity Forum Stanford in Review 1981 Box 7, Folder 29 Language and the Brain 1975 Box 7, Folder 30 FDA Related Correspondence 1979-1982 Box 8 Chronological files 1993-1995 Accession ARCH-2009-139 Papers Box 1, Folder 1 Human Biology & Public Policy University Seminar 11/21/75 (#AA) Box 1, Folder 2 Clockwork Versus Value – Harvard Class Day 5/25/79 (#1A) Box 1, Folder 3 Stanford Executive Program Bishop Auditorium August 1, 1979 2-3:15pm Box 1, Folder 4 Jackson Laboratory's 1979 Anniversary Speaker Series Bar Harbor, Maine August 8-12, 1979 Box 1, Folder 5 WIERSMA Memorial Service 10/2/79 (#4) Box 1, Folder 6 WIERSMA Memorial Remarks 10/2/79 and General Biology Seminar – Cal Tech 10/2/79 (#5) Box 1, Folder 7 SF Major Gifts Committee 10/23/79 Box 1, Folder 8 Stanford Homeowners Assn. Talk 11/14/79 Box 1, Folder 9 Management Development Group November 16, 1979 Box 1, Folder 10 Stanford Industrial Affiliates Symposia Science, Regulation, and Risk Aversion December 3, 1979 (Banquet) Faculty Club (#11) Box 1, Folder 11 Food and Drug Law Institute 30th Anniversary Annual Banquet Washington, D.C. December 11, 1979 (#12) Box 1, Folder 12 Forsythe Dedication 1/14/80 (#13) Box 1, Folder 13 Pills & the Public Purse 1/30/80 (#14A) Box 1, Folder 14 Pills and the Public Purse Foreword 1/30/80 Box 1, Folder 15 Drug and Device Regulation: The Government's Role Snowmass January 14-18, 1980 (#15) Box 1, Folder 16 DK's Fundraising Trip to NY 2/4-7/80 (#16) Box 1, Folder 17 Swopsi Lecture: A Look at Health Regulation: The Food Safety Laws 2/7/80 (#17) Box 1, Folder 18 Frontiers of Science Series University of Utah Salt Lake City, Utah February 15-17, 1980 (#18) Box 1, Folder 19 Committee for Art Board of Governors 2/19/80 (#19) Box 1, Folder 20 Libraries Group 2/22/80 (#20) Box 1, Folder 21 Commonwealth Club S.F. 2/29/80 (#21) Box 1, Folder 22 Commonwealth Club (#21) Box 1, Folder 23 Science and Health Regulation Journal of Dental Education 3/80 (#22) Box 1, Folder 24 Politics of Health Western Assn. of Venture Capitalists 3/11/80 (#23) Box 1, Folder 25 PEP Dedication 9/5/80 Box 1, Folder 26 Medical School 20th Anniversary Symposium Dinner 3/27/80 (#24) Box 1, Folder 27 California Academy of Medicine San Francisco St. Francis Hotel Saturday, March 29, 1980 (#25) Box 1, Folder 28 Regulation: Both Sides of the Barrier April, 1980 (#26) Box 1, Folder 29 Regulation: Both Sides of the Barrier 4/80 (#26) Box 1, Folder 30 Meetings, Donor P.R. Washington/Boston/Chicago/New York April 20-26, 1980 (#27) Box 1, Folder 31 GSB Advisory Council May 1, 1980 (#28) Box 1, Folder 32 Wilson Riles introduction Univ.
Load more

Recommended publications
  • Overruling the Food and Drug Administration
    Overruling the Food and Drug Administration: An Analysis of the 2011 Denial of Over-the-Counter Status for Plan B Placed within the Historical Context of Executive Influence on FDA Action The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Alisha Crovetto, Overruling the Food and Drug Administration: An Analysis of the 2011 Denial of Over-the-Counter Status for Plan B Placed within the Historical Context of Executive Influence on FDA Action (May 2012). Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10985168 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Overruling the Food and Drug Administration: An Analysis of the 2011 Denial of Over-the-Counter Status for Plan B Placed within the Historical Context of Executive Influence on FDA Action Alisha Crovetto Harvard Law School J.D. Candidate, 2013 May 2012 Food & Drug Law Course Paper Abstract On December 7, 2011, newspaper headlines from coast to coast announced that Plan B One-Step, a form of emergency contraception, would not be made available to females under seventeen without a prescription. The denial of over-the-counter (“OTC”) status, though newsworthy itself, drew particular attention because of the unusual nature of the decision. As the New York Times announced, “[f]or the first time ever, the Health and Human Services secretary publicly overruled the Food and Drug Administration .
    [Show full text]
  • Masakazu Konishi
    Masakazu Konishi BORN: Kyoto, Japan February 17, 1933 EDUCATION: Hokkaido University, Sapporo, Japan, B.S. (1956) Hokkaido University, Sapporo, Japan, M.S. (1958) University of California, Berkeley, Ph.D. (1963) APPOINTMENTS: Postdoctoral Fellow, University of Tübingen, Germany (1963–1964) Postdoctoral Fellow, Division of Experimental Neurophysiology, Max-Planck Institut, Munich, Germany (1964–1965) Assistant Professor of Biology, University of Wisconsin, Madison (1965–1966) Assistant Professor of Biology, Princeton University (1966–1970) Associate Professor of Biology, Princeton University (1970–1975) Professor of Biology, California Institute of Technology (1975– 1980) Bing Professor of Behavioral Biology, California Institute of Technology (1980– ) HONORS AND AWARDS (SELECTED): Member, American Academy of Arts and Sciences (1979) Member, National Academy of Sciences (1985) President, International Society for Neuroethology (1986—1989) F. O. Schmitt Prize (1987) International Prize for Biology (1990) The Lewis S. Rosenstiel Award, Brandeis University (2004) Edward M. Scolnick Prize in Neuroscience, MIT (2004) Gerard Prize, the Society for Neuroscience (2004) Karl Spencer Lashley Award, The American Philosophical Society (2004) The Peter and Patricia Gruber Prize in Neuroscience, The Society for Neuroscience (2005) Masakazu (Mark) Konishi has been one of the leaders in avian neuroethology since the early 1960’s. He is known for his idea that young birds initially remember a tutor song and use the memory as a template to guide the development of their own song. He was the fi rst to show that estrogen prevents programmed cell death in female zebra fi nches. He also pioneered work on the brain mechanisms of sound localization by barn owls. He has trained many students and postdoctoral fellows who became leading neuroethologists.
    [Show full text]
  • The Need to Shorten the Prescription Drug Approval Process
    Valparaiso University Law Review Volume 27 Number 1 Fall 1992 pp.95-137 Fall 1992 Getting There First With the Best: The Need to Shorten the Prescription Drug Approval Process Mark A. Kassel Follow this and additional works at: https://scholar.valpo.edu/vulr Part of the Law Commons Recommended Citation Mark A. Kassel, Getting There First With the Best: The Need to Shorten the Prescription Drug Approval Process, 27 Val. U. L. Rev. 95 (1992). Available at: https://scholar.valpo.edu/vulr/vol27/iss1/3 This Notes is brought to you for free and open access by the Valparaiso University Law School at ValpoScholar. It has been accepted for inclusion in Valparaiso University Law Review by an authorized administrator of ValpoScholar. For more information, please contact a ValpoScholar staff member at [email protected]. Kassel: Getting There First With the Best: The Need to Shorten the Presc Notes GETTING THERE FIRST WITH THE BEST: THE NEED TO SHORTEN THE PRESCRIPTION DRUG APPROVAL PROCESS I. INTRODUCTION Due to unnecessary time delays, high costs and safety concerns, drug regulation in the United States is in need of reform.' The United States consistently lags behind the rest of the developed world in the approval of new, innovative, and efficient medications.2 Therefore, the Food and Drug Administration (FDA) needs to implement creative and effective changes in the prescription drug approval process3 in order to protect the health of the American public. Most Americans think that the FDA's stringent process for approving new prescription drugs guarantees that prescription drugs are successfully monitored.4 The American public assumes that safe and innovative drugs are made available to the public as quickly' and cost effectively6 as possible, while unsafe7 products are kept off the market.' However, this confidence placed in the FDA is unwarranted.
    [Show full text]
  • Donald Griffin Was Able to Affect a Major Revolution in What Scien- Tists Do and Think About the Cognition of Nonhuman Ani- Mals
    NATIONAL ACADEMY OF SCIENCES DONALD R. GRIFFIN 1915– 2003 A Biographical Memoir by CHARLES G. GROSS Any opinions expressed in this memoir are those of the author and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoirs, VOLUME 86 PUBLISHED 2005 BY THE NATIONAL ACADEMIES PRESS WASHINGTON, D.C. DONALD R. GRIFFIN August 3, 1915–November 7, 2003 BY CHARLES G. GROSS OST SCIENTISTS SEEK—but never attain—two goals. The M first is to discover something so new as to have been previously inconceivable. The second is to radically change the way the natural world is viewed. Don Griffin did both. He discovered (with Robert Galambos) a new and unique sensory world, echolocation, in which bats can perceive their surroundings by listening to echoes of ultrasonic sounds that they produce. In addition, he brought the study of animal consciousness back from the limbo of forbidden topics to make it a central subject in the contemporary study of brain and behavior. EARLY YEARS Donald R. (Redfield) Griffin was born in Southampton, New York, but spent his early childhood in an eighteenth- century farmhouse in a rural area near Scarsdale, New York. His father, Henry Farrand Griffin, was a serious amateur historian and novelist, who worked as a reporter and in advertising before retiring early to pursue his literary inter- ests. His mother, Mary Whitney Redfield, read to him so much that his father feared for his ability to learn to read. His favorite books were Ernest Thompson Seton’s animal 3 4 BIOGRAPHICAL MEMOIRS stories and the National Geographic Magazine’s Mammals of North America.
    [Show full text]
  • The National Academies Committee on a New Government-University
    NOTE: This is an unedited verbatim transcript of the Workshop on a New Government-University Partnership for Science and Security held at Stanford University on September 27-28, 2006. It was prepared by CASET Associates and is not an official report of The National Academies. Opinions and statements included in the transcript are solely those of the individual persons or participants at the workshop, and are not necessarily adopted or endorsed or verified as accurate by The National Academies. The National Academies Committee on a New Government-University Partnership for Science and Security September 28, 2006 Stanford University Bechtel Conference Center 616 Serra Mall, Encina Hall Stanford, CA Proceedings by: CASET Associates, Ltd. 10201 Lee Highway, suite 180 Fairfax, Virginia 22030 (703) 352-0091 NOTE: This is an unedited verbatim transcript of the Workshop on a New Government-University Partnership for Science and Security held at Stanford University on September 27-28, 2006. It was prepared by CASET Associates and is not an official report of The National Academies. Opinions and statements included in the transcript are solely those of the individual persons or participants at the workshop, and are not necessarily adopted or endorsed or verified as accurate by The National Academies. TABLE OF CONTENTS Page Introductions and Purpose of Meeting Jacques S. Gansler and Alice P. Gast 1 Security Concerns at National and University Laboratories Siegfried S. Hecker 3 Discussion 26 International Collaborations Jonathan Dorfan 40 Discussion 56 National Security and Academic Publishing Donald Kennedy 64 Discussion 77 Open Discussion: Moving Forward 86 NOTE: This is an unedited verbatim transcript of the Workshop on a New Government-University Partnership for Science and Security held at Stanford University on September 27-28, 2006.
    [Show full text]
  • The FDAAA's New Website
    Recipient of the Frances O. Kelsey Award for Courage and Excellence in Protecting the Public Health The FDAAA’s New Website (Still at www.fdaaa.org ) We are so pleased to unveil our new website. Not only is this modernized website more attractive and easier to follow, it has great new features such as members-only access to a growing collection of FDA- related information, a skills inventory, and the ability to chat with other members behind a secure firewall. This website will take us into a new era when FDAAA does even more to support your ongoing enrichment, connection to each other and to FDA, and your ability to locate resources, colleagues, friends, and experts. The FDA Alumni Association is the official global network of former and current FDA employees, connecting and supporting alumni, the Agency, and the public health community. Please be active in FDAAA and help us to make a difference. In speaking about FDAAA, then-Commissioner Ned Sharpless recently reminded us of a key quote from Margaret Mead: “Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it’s the only thing that ever has.” Members are encouraged to visit the Newsletter - Updates for the latest edition of the Newsletter, July 2020. Deb Autor, Chair Board of Directors FDA ALUMNI ASSOCIATION SAVE THE DATE…for our first FDA Alumni Association VIRTUAL Speaker Series Event! We are thrilled to have Dr. Luciana Borio (former Director for Medical and Biodefense Preparedness Policy for the White House National Security Council and former Acting Chief Scientist and Assistant Commissioner for Counterterrorism and Emerging Threats at FDA ) as our guest speaker on COVID-19 issues.
    [Show full text]
  • Improving the Efficiency of the Later Stages of the Drug Development Process: Survey Results from the Industry, Academia, and the FDA
    Improving the Efficiency of the Later Stages of the Drug Development Process: Survey Results from the Industry, Academia, and the FDA By Adrian Hedley Benjamin Gottschalk B.S. Biochemistry Texas A&M University, 1997 M.B.A. MIT Sloan School of Management, 2003 SUBMITTED TO THE HARVARD-MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN HEALTH SCIENCES AND TECHNOLOGY AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY JUNE 2004 © 2004 Massachusetts Institute of Technology All rights reserved Signature of Author: ____________________________________________________________ Harvard-MIT Division of Health Sciences and Technology May 7, 2004 Certified by: __________________________________________________________________ Ernst R. Berndt Professor of Applied Economics Thesis Co-supervisor Certified by: __________________________________________________________________ Joseph V. Bonventre Professor of Medicine and Health Sciences and Technology Co-Director, Harvard-MIT Division of Health Sciences and Technology Thesis Co-supervisor Accepted by: __________________________________________________________________ Martha Gray Professor of Medical and Electrical Engineering Co-Director, Harvard-MIT Division of Health Sciences and Technology Improving the Efficiency of the Later Stages of the Drug Development Process: Survey Results from the Industry, Academia, and the FDA By Adrian Hedley Benjamin Gottschalk Submitted to the Harvard-MIT Division of Health Sciences and Technology on May 7, 2004 in Partial Fulfillment of the Requirements for the Degree of Master of Science in Biomedical Enterprise ABSTRACT Drug development in the United States is a lengthy and expensive endeavor. It is estimated that average development times range from eleven to fifteen years and exceed costs of one billion dollars. The development pathway includes basic scientific discovery, pre-clinical testing in animals, clinical development in humans, and an application process.
    [Show full text]
  • Stanford Lawyer Spring/Summer 1981 Volume 16, NO.1
    Stanford Lawyer Spring/Summer 1981 Volume 16, NO.1 Editor: Cheryl W. Ritchie Associate Editor: Sara Wood Designer: Jim M'Guinness Dean's Page 2 Charles J. Meyers: A Leader in the Stanford Tradition 4 An Interview with the School's Eighth Dean Mediation-An Alternative to Adversary Divorce 10 by George H. Norton '57 Child Custody Disputes: Are We Abandoning the Child's 16 Best Interests? by Michael S. Wald, Professor of Law Home v. Public Education: Should Parents Have the Right 20 To Choose? by Thomas J. Owen '81 and Marjorie Horton Thinking About Children's Rights-Moving Beyond Kiddie Libbers 24 and Child Savers by Robert H. Mnookin, Visiting Professor of Law Stanford's Clinical Course in Juvenile Law: Combining Simulated 31 with Actual Courtroom Experience And When They're Not Practicing Law. .. 33 How Seven Alumni Spend Their uLeisure" Time Faculty Opinion: Putting the Crisis in EI Salvador in Perspective 39 by William B. Gould, Professor of Law Kudos for Stanford Supreme Court Advocate 40 Nation's First Professorship in Law and Business Established 41 at the School School and Faculty News 42 Class Notes 51 In Memoriam 71 Stanford Lawyer is published semi-annually for alumni/ae and friends of Stanford Law School. Materials for publication and correspondence are welcome and should be sent to the Editor, Stanford Lawyer, Stanford Law School, Crown Quadrangle, Stanford, CA 94305. ©1981 by the,Board of Trustees of the Leland Stanford Junior University. Reproduction in whole or in part without permission of the publisher is prohibited. Cover: Portrait of Dean Charles J.
    [Show full text]
  • Robert Hahn Testimony
    R E G - M A R K E T S C E N T E R AEI Center for Regulatory and Market Studies The Future of the Internet Robert W. Hahn Testimony before the Senate Committee on Commerce, Science and Transportation Testimony 08-01 April 2008 * Robert Hahn is executive director of the Reg-Markets Center and a senior fellow at AEI, and a non-resident senior fellow at Brookings. He would like to thank Caroline Cecot and Molly Wells for research assistance. This testimony builds on research that I have done with a number of colleagues, including Robert Crandall, Robert Litan, Hal Singer, and Scott Wallsten. The views expressed in this paper reflect solely those of the author and do not necessarily reflect those of the institutions with which he is affiliated. R E G - M A R K E T S C E N T E R AEI Center for Regulatory and Market Studies The Reg-Markets Center focuses on understanding and improving regulation, market performance, and government policy. The Center provides analyses of key issues aimed at improving decisions in the public, private and not-for-profit sectors. It builds on the success of the AEI-Brookings Joint Center. The views expressed in this publication are those of the authors. ROBERT HAHN Executive Director COUNCIL OF ACADEMIC ADVISERS ROBERT E. LITAN, Co-Chairman CASS R. SUNSTEIN, Co-Chairman Brookings Institution University of Chicago KENNETH J. ARROW ROBERT CRANDALL MAUREEN CROPPER Stanford University Brookings Institution University of Maryland JOHN D. GRAHAM PAUL L. JOSKOW DONALD KENNEDY Pardee RAND Massachusetts Institute Stanford University Graduate School of Technology MARK MCCLELLAN ROGER G.
    [Show full text]
  • April 25, 2013 Kathleen Sebelius Secretary, Health and Human
    April 25, 2013 Kathleen Sebelius Secretary, Health and Human Services 200 Independence Avenue, S.W. Washington, D.C. 20201 [email protected] Cc: Bob Perciasepe Acting Administrator, US Environmental Protection Agency Ariel Rios Building, 4101 M 1200 Pennsylvania Avenue, N.W. Washington, DC 20460 [email protected] Dr. Margaret A. Hamburg Commissioner, U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 [email protected] Dear Secretary Sebelius: We, the undersigned, represent a wide range of research scientists, public-interest and consumer organizations with an interest in the federal government’s advice regarding fish consumption, methylmercury in seafood, and health. The current US advisory on this topic, issued by EPA and FDA in March 2004, was developed in 2003, based on studies published in the 1990s, and is now out of date and insufficiently protective of public health. Research carried out in the past decade has both clarified the beneficial nutritional effects of fish consumption during pregnancy and found adverse effects of prenatal methylmercury exposure at very low doses, at least an order of magnitude below exposures known to be harmful when the current Advisory was written. Consumers, the public health community, state health officials and others who advise the public on the benefits and risks of seafood consumption therefore urgently need an up-to-date federal statement on this topic. In 2009, FDA began a process to update the 2004 Advisory by publishing a draft assessment of benefits and risks of fish consumption for public comment. That draft was criticized by many commenters (including some signers of this letter) for a variety of scientific weaknesses.
    [Show full text]
  • Ethanol: Law, Economics, and Politics
    R E G - M A R K E T S C E N T E R Ethanol: Law, Economics, and Politics Robert W. Hahn* Working Paper 08-02 January 2008 This paper is forthcoming in the Stanford Law and Policy Review. This paper can be downloaded free of charge from the Social Science Research Network at http://ssrn.com/abstract=1082079 * Mr. Hahn is co-founder and executive director of the AEI-Brookings Joint Center and a scholar at AEI. He would like to thank Bruce Gardner and Al McGartland for helpful comments. He especially thanks Peter Nagelhout for answering detailed questions about the underlying economic and environmental components of ethanol. Caroline Cecot, Ryan Hughes, and Molly Wells provided valuable research assistance. The views expressed in this paper reflect those of the author and do not necessarily reflect those of the institutions with which he is affiliated. R E G - M A R K E T S C E N T E R AEI Center for Regulatory and Market Studies The Reg-Markets Center focuses on understanding and improving regulation, market performance, and government policy. The Center provides analyses of key issues aimed at improving decisions in the public, private and not-for-profit sectors. It builds on the success of the AEI-Brookings Joint Center. The views expressed in this publication are those of the authors. ROBERT HAHN Executive Director COUNCIL OF ACADEMIC ADVISERS ROBERT E. LITAN, Co-Chairman CASS R. SUNSTEIN, Co-Chairman Brookings Institution University of Chicago KENNETH J. ARROW ROBERT CRANDALL MAUREEN CROPPER Stanford University Brookings Institution University of Maryland JOHN D.
    [Show full text]
  • Research Report 26, Including the Report of the HEI Review Committee
    Investigation of a Potential Cotumorigenic Effect of the Dioxides of Nitrogen and Sulfur, and of Diesel-Engine Exhaust, on the Respiratory Tract of Syrian Golden Hamsters Uwe Heinrich, Ulrich Mohr, Rainer Fuhst, and Carsten Brockmeyer FraunhoJer Institute for Toxicology and Aerosol Research, Hannover, Federal Republic of Germany Includes the Report of the Institute's Health Review Committee Research Report Number 26 The Health Effects Institute (HEI) is a nonprofit corporation founded in 1980 to assure that objective, credible, high-quality scientific studies are conducted on the potential human health effects of motor vehicle emissions. Funded equally by the U.S. Environmental Protection Agency (EPA) and 27 automotive manufacturers or marketers in the United States, HEI is independently governed. Its research projects are selected, conducted, and evaluated according to a careful public process, including a rigorous peer review process, to assure both credibility and high scientific standards. HEI makes no recommen­ dations on regulatory and social policy. Its goal, as stated by former EPA Administrator William D. Ruckelshaus, is "simply to gain acceptance by all parties of the data that may be necessary for future regulations." The Board of Directors Archibald Cox Chairman Donald Kennedy Carl M. Loeb University Professor (Emeritus), Harvard Law School President, Stanford University Charles W. Powers William 0. Baker Partner, Resources for Responsible Management; Founding Executive Chairman (Emeritus), Bell Laboratories Director, HE! Health Research Committee Walter A. Rosenblith Chairman Robert F. Sawyer Institute Professor (Emeritus), Massachusetts Institute of 1cchnology Professor of Mechanical Engineering, University of California, Berkeley Joseph D. Brain John W. Tukey Cecil K. and Philip Drinker Professor of Environmental Physiology, Senior Research Statistician; and Donner Professor of Science Emeritus, Harvard University School of Public Health Princeton University Mark Utell Curtis C.
    [Show full text]